Interestingly, “beiging” of eWAT correlated with increased expression of Wnt10b and IGFBP2, two endocrine/paracrine factors recognized for their anti-obesity and bone anabolic activity [44]–[46]. This evidence concerns the gene IGFBP2 and obesity due to melanocortin 4 receptor deficiency.